TrialInvestigational new drugs2013

Phase II clinical study of modified FOLFOX7 (intermittent oxaliplatin administration) plus bevacizumab in patients with unresectable metastatic colorectal cancer-CRAFT study.

Tohru Tezuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.